4.03MMarket Cap
LossP/E TTM
Galmed Pharmaceuticals Ltd
GLMD Financials
See Galmed Pharmaceuticals Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Galmed Pharmaceuticals Ltd Earnings Date
Latest Release
Jul 8, 2026
EPS / Forecast
-0.29/-0.38
Analyst Rating
HOLD
2025/12/09
FAQs
What are the current assets of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its current assets were 18.63M, with a year-on-year change of 15.52.
What are the total assets of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total assets of Galmed Pharmaceuticals Ltd were 18.63M, with a year-on-year change of 0.69.
What are the total liabilities of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total liabilities of Galmed Pharmaceuticals Ltd were 2.85M, with a year-on-year change of 30.92.
What is the total equity of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its total equity of Galmed Pharmaceuticals Ltd was 15.78M, with a year-on-year change of -3.34.
What is the net operating income of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net operating income of Galmed Pharmaceuticals Ltd was -8.51M, with a year-on-year change of -35.55.
What is the net investment of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net investment of Galmed Pharmaceuticals Ltd was -3.38M, with a year-on-year change of -203.78.
What is the net financing of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net financing of Galmed Pharmaceuticals Ltd was 9.03M, with a year-on-year change of 2.73.
What is the Earnings Per Share (EPS) of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -2.39, with a year-on-year change of 70.39.
What is the net income of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its net income was -10.31M, with a year-on-year change of -37.14.
What is the Return on Equity (ROE) of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Return on Equity (ROE) was -64.21, with a year-on-year change of -29.01.
What is the Return on Assets (ROA) of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its Return on Assets (ROA) was -55.53, with a year-on-year change of -29.76.
What is the operating profit of Galmed Pharmaceuticals Ltd?
According to Galmed Pharmaceuticals Ltd's FY2025 earnings report, its operating profit was -8.51M, with a year-on-year change of -35.55.